Tenderwize
Retour à la recherche

Open House Discount Agreements for Certolizumab pegol, ATC L04AB05

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Feb 28, 2027 · 131 days left·Open·Supplies
Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Certolizumab pegol , ATC L04AB05

40/100

Score d'opportunité

Needs reviewLow complexity
SuppliesOpen
Pourquoi ce score ?

Opportunité

40 / 100

Complexité

20 / 100

Facteurs de risque

Non-exclusive contracts mean market share is not guaranteed; multiple competitors may participate, diluting potential v...

Buyer may replace open-house contracts with exclusive agreements at any time, terminating these contracts early.

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
Pays
Allemagne
CPV
33600000 - Pharmaceutical products
Date limite
Feb 28, 2027

Aperçu

Moderate opportunity

Faits clés

  • Supplies contract
  • 1 lot
  • Duration until Apr 2027
  • Conclusion of non-exclusive discount agreements for Certolizumab pegol (ATC L04AB05) under the open-house model.
  • Contracts have uniform terms and conditions, no individual negotiations.
Afficher le résumé complet

Non-exclusive discount agreement (open-house model) for the active substance Certolizumab pegol (ATC L04AB05), offered by AOK Rheinland-Pfalz/Saarland. All interested pharmaceutical companies meeting eligibility may join at uniform terms. Contracts run max 24 months (earliest start 01.05.2025, ending 30.04.2027). The buyer may replace with exclusive contracts during the term. First submission deadline: 31.03.2025; subsequent monthly deadlines. Notice is a voluntary transparency publication, not a formal EU procurement.

Risques

Non-exclusive contracts mean market share is not guaranteed; multiple competitors may participate, diluting potential v...

Buyer may replace open-house contracts with exclusive agreements at any time, terminating these contracts early.

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Evidence of marketability via Lauer-Taxe listing or AMIce database extract required.

Eligibility

  • Only pharmaceutical products authorized and marketable in Germany are eligible.

Administrative

  • Submission of signed contract documents and required evidence by the specified deadlines.

Critères d'attribution

Lot 1

No award criteria are applied as the open-house model accepts all qualifying participants. Eligibility is the sole condition.

Acheteur

Localisation

Eisenberg, DEU

Profil acheteur

Ouvrir le profil

Identifiant

DE271900642

Activité

Health

Lots (1)

LOT-0001

Open House Discount Agreements for Certolizumab pegol, ATC L04AB05

Non-exclusive discount contracts for the supply of pharmaceutical products containing the active substance Certolizumab pegol (ATC L04AB05) to the AOK Rheinland-Pfalz/Saarland. All qualified pharmaceutical companies can join on standard terms. Duration: up to 24 months from 01.05.2025 to 30.04.2027. Rolling entry possible monthly. Uniform conditions, no negotiations. Subject to early termination if buyer awards exclusive contracts.

SuppliesEU fundedElectronic submission

Localisation

Eisenberg, Germany

Durée

Apr 2025 - Apr 2027

Catégorie

Pharmaceutical products

Critères d'attribution

No award criteria are applied as the open-house model accepts all qualifying participants. Eligibility is the sole condition.

Date limite

Deadline Feb 28, 2027

Détails de la procédure

Date de publication
12 Mar 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
164685-2025

Documents (1)

Appels d'offres similaires